Recent advances in the molecular design and applications of proteolysis targeting chimera-based multi-specific antiviral modality
Viral infections represent a major threat to human health and the global economy; however, most of the currently available antiviral drugs are not fully effective in restricting viral replication and selecting for drug-resistant variants. Targeted protein degradation technologies are promising strat...
Saved in:
Main Authors: | Yang Zhou (Author), Shujing Xu (Author), Nerea López-Carrobles (Author), Dang Ding (Author), Xinyong Liu (Author), Luis Menéndez-Arias (Author), Peng Zhan (Author) |
---|---|
Format: | Book |
Published: |
Compuscript Ltd,
2023-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Proteolysis-targeting chimeras and their implications in breast cancer
by: Angeles C. Tecalco-Cruz, et al.
Published: (2021) -
The clinical advances of proteolysis targeting chimeras in oncology
by: Hao Xie, et al.
Published: (2021) -
Cancer-Specific Delivery of Proteolysis-Targeting Chimeras (PROTACs) and Their Application to Cancer Immunotherapy
by: Yujeong Moon, et al.
Published: (2023) -
Research advances of proteolysis targeting chimeras for acute kidney injury
by: Jun-dan Jia, et al.
Published: (2024) -
PROteolysis Targeting Chimeras: A new cutting‐edge nanomedicine for colorectal cancer
by: Swastika Maitra, et al.
Published: (2024)